SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-22-000822
Filing Date
2022-04-20
Accepted
2022-04-20 11:20:37
Documents
24
Period of Report
2022-04-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 24058
2 EX-99.1 lxrp_ex991.htm EX-99.1 5710
8 lxrp_ex991img7.jpg GRAPHIC 127046
9 lxrp_ex991img9.jpg GRAPHIC 202992
10 lxrp_ex991img1.jpg GRAPHIC 232878
11 lxrp_ex991img2.jpg GRAPHIC 245926
12 lxrp_ex991img3.jpg GRAPHIC 291904
13 lxrp_ex991img4.jpg GRAPHIC 372677
14 lxrp_ex991img5.jpg GRAPHIC 153371
15 lxrp_ex991img6.jpg GRAPHIC 167969
16 lxrp_ex991img8.jpg GRAPHIC 104017
  Complete submission text file 0001640334-22-000822.txt   2769839

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20220419.xsd EX-101.SCH 5830
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20220419_lab.xml EX-101.LAB 14731
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20220419_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20220419_pre.xml EX-101.PRE 9356
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20220419_def.xml EX-101.DEF 2103
18 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 3601
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 22836948
SIC: 2834 Pharmaceutical Preparations